Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells
- 30 November 2012
- journal article
- Published by Elsevier BV in The International Journal of Biochemistry & Cell Biology
- Vol. 44 (11), 1993-2002
- https://doi.org/10.1016/j.biocel.2012.07.028
Abstract
No abstract availableKeywords
Funding Information
- FONDECYT (1120380, 1121078, 1110426)
- CARE (PFB12/2007)
- CONICYT (AT-24100061 and AT-24100047)
- MDA (89419)
- UNAB (DI 33-11/R)
This publication has 46 references indexed in Scilit:
- Fibrotic response induced by angiotensin-II requires NAD(P)H oxidase-induced reactive oxygen species (ROS) in skeletal muscle cellsBiochemical and Biophysical Research Communications, 2011
- Transient receptor potential melastatin 4 inhibition prevents lipopolysaccharide-induced endothelial cell deathCardiovascular Research, 2011
- Connective tissue growth factor induction by lysophosphatidic acid requires transactivation of transforming growth factor type β receptors and the JNK pathwayCellular Signalling, 2011
- A Novel Modulatory Mechanism of Transforming Growth Factor-β Signaling through Decorin and LRP-1Online Journal of Public Health Informatics, 2007
- Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated ratsHepatology, 2005
- Liver fibrosisJCI Insight, 2005
- Connective tissue growth factor—a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in ratsJournal of Molecular and Cellular Cardiology, 2004
- Lisofylline, a Novel Antiinflammatory Compound, Protects Mesangial Cells from Hyperglycemia- and Angiotensin II-Mediated Extracellular Matrix DepositionEndocrinology, 2003
- NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosisJCI Insight, 2003
- Angiotensin II and Cardiac FibrosisTrends in Cardiovascular Medicine, 1996